Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide

Author(s):  Zur Eyal

Issue:  Jul/Aug 2012 - Volume 16, Number 4
View All Articles in Issue

Page(s):  288-293

Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide Page 1
Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide Page 2
Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide Page 3
Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide Page 4
Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide Page 5
Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide Page 6

Download in electronic PDF format for $75

Abstract:  Eosinophilic esophagitis is a clinicopathologic disease isolated to the esophagus. It is caused by immunologic reactions to ingested and inhaled allergans. Symptoms include regurgitation, vomiting, pain, anorexia, and dysphagia. Endoscopy with biopsy is currently the only reliable diagnostic test for eosinophilic esophagitis. The disease should remit with treatments of dietary exclusion, topical corticosteroids, or both. Oral viscous budesonide is one of the promising options of topical corticosteroid to treat eosinophilic esophagitis. Since there are no commercial medicines of oral viscous budesonide, it is solely a compounded medication. This article briefly discusses the properties of the disease and covers a few compounding possibilities to oral viscous budesonide.

Related Keywords: Eyal Zur, RPh, MBA, eosinophilic esophagitis, esophagus, immunologic reaction, allergens, dietary restrictions, topical administration, oral gel, viscous budesonide, topical corticosteroid, steroid gel, formulation

Related Categories: EAR NOSE THROAT, FORMULATIONS, ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide
Zur Eyal
Jul/Aug 2012
Pg. 288-293

Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus
Zur Eyal
Sep/Oct 2019
Pg. 376-381

Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox)
Ip Kendice
, Carvalho Maria, Shan Ashley, Banov Daniel
Jul/Aug 2017
Pg. 322-329

Budesonide 0.0.25% Mucoadhesive Gel
Allen Loyd V Jr
Jul/Aug 2021
Pg. 323

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

Lidocaine Hydrochloride 2% Viscous Oral Topical Solution
Allen Loyd V Jr
May/Jun 2015
Pg. 243

Budesonide 1-mg//10-mL Mucolox Oral Suspensions
Allen Loyd V Jr
Jul/Aug 2018
Pg. 317

Women's Oral Health: Is There a Hormonal Link?
Preckshot John
Jan/Feb 2004
Pg. 10-14

Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents
Zur Eyal
Nov/Dec 2012
Pg. 462-469

Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Klemmer Anja
, Krämer Irene, Kamin Wolfgang
May/Jun 2013
Pg. 254-261

Sensitization Therapy for Warts
Kuntz Rachael
Jul/Aug 2003
Pg. 266-270

Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Zur Eyal
Nov/Dec 2011
Pg. 458-463

Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory
, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Sep/Oct 2015
Pg. 357-365

Utilization of Compounded Medications in an Oral Medicine Practice
Stock Shannon
, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
Mar/Apr 2016
Pg. 155-158

Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

Pediatric Compounding: Coloring Outside the Lines
Preckshot John
Jan/Feb 2001
Pg. 6-8

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3
Zur Eyal
Sep/Oct 2019
Pg. 366-375

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2
Zur Eyal
Jul/Aug 2019
Pg. 288-293

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1
Zur Eyal
May/Jun 2019
Pg. 200-207

Case Report: Topical Gel for the Treatment of a Refractory Leg Ulcer
Israel Alan
May/Jun 2003
Pg. 176-178

Return to Top